1. |
Stephen YN, Thomas HS. Campbell's urology. 10th ed. Philadelphia:W.B. Saunders, 2012:3599-3628.
|
2. |
Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet, 2005, 365(9477):2125-2136.
|
3. |
Gozar H, Pascanu I, Ardelean M, et al. Surgical reconstruction of the genitalia in a 3-year-old infant with a 46XX karyotype:case report. Aesthetic Plast Surg, 2014, 38(3):549-553.
|
4. |
Sturm RM, Durbin-Johnson B, Kurzrock EA. Congenital adrenal hyperplasia:current surgical management at academic medical centers in the United States. J Urol, 2015, 193(5 Suppl):1796-1801.
|
5. |
Latrech H, Skikar I, Gharbi Mel H, et al. Disorder of sexual development and congenital heart defect in 47XYY:clinical disorder or coincidence? Case Rep Endocrinol, 2015, 2015:802162.
|
6. |
Nakashima S, Ohishi A, Takada F, et al. Clinical and molecular studies in four patients with SRY-positive 46, XX testicular disorders of sex development:implications for variable sex development and genomic rearrangements. J Hum Genet, 2014, 59(10):549-553.
|
7. |
Juniarto AZ, van der Zwan YG, Santosa A, et al. Application of the new classification on patients with a disorder of sex development in Indonesia. Int J Endocrinol, 2012, 2012:237084.
|
8. |
Guercio G, Rey RA. Fertility issues in the management of patients with disorders of sex development. Endocr Dev, 2014, 27:87-98.
|
9. |
杨洋, 周晓玉, 周晓光. 21-羟化酶缺乏先天性肾上腺皮质增生症52例临床分析.中国当代儿科杂志, 2015, 17(6):613-617.
|
10. |
梁玲, 辛颖. 47例先天性肾上腺皮质增生症的临床特点及诊治分析.中国优生与遗传杂志, 2014, 22(1):119-121.
|
11. |
Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency:an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2010, 95(9):4133-4160.
|
12. |
Speiser PW, Azziz R, Baskin LS, et al. A summary of the endocrine society clinical practice guidelines on congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. Int J Pediatr Endocrinol, 2010, 2010:494173.
|
13. |
Reifsnyder JE, Stites J, Stites J, et al. Nerve sparing clitoroplasty is an option for adolescent and adult female patients with congenital adrenal hyperplasia and clitoral pain following prior clitoral recession or incomplete reduction. J Urol, 2016, 195(4 Pt 2):1270-1274.
|
14. |
Yankovic F, Cherian A, Steven L, et al. Current practice in feminizing surgery for congenital adrenal hyperplasia; a specialist survey. J Pediatr Urol, 2013, 9(6 Pt B):1103-1107.
|
15. |
Park S, Ha SH, Kim KS. Long-term follow-up after feminizing genital reconstruction in patients with ambiguous genitalia and high vaginal confluence. J Korean Med Sci, 2011, 26(3):399-403.
|
16. |
Leslie JA, Cain MP, Rink RC. Feminizing genital reconstruction in congenital adrenal hyperplasia. Indian J Urol, 2009, 25(1):17-26.
|
17. |
Savanelli A, Alicchio F, Esposito C, et al. A modified approach for feminizing genitoplasty. World J Urol, 2008, 26(5):517-520.
|
18. |
Poppas DP, Hochsztein AA, Baergen RN, et al. Nerve sparing ventral clitoroplasty preserves dorsal nerves in congenital adrenal hyperplasia. J Urol, 2007, 178(4 Pt 2):1802-1806.
|
19. |
Pippi Salle JL, Braga LP, Macedo N, et al. Corporeal sparing dismembered clitoroplasty:an alternative technique for feminizing genitoplasty. J Urol, 2007, 178(4 Pt 2):1796-1800.
|
20. |
林小梅, 吴本清, 黄进洁, 等.先天性肾上腺皮质增生症1例CYP21A2基因突变分析.中国当代儿科杂志, 2013, 15(11):942-947.
|
21. |
Chen W, Xu Z, Nishitani M, et al. Complement component 4 copy number variation and CYP21A2 genotype associations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Genet, 2012, 131(12):1889-1894.
|